CCL2 and familial dilated cardiomyopathy: Lehmann et al. [68] found that DCM patients with a more serious decline in left ventricular function had increased levels of MCP-1 messenger RNA than those with less severe symptoms, implying that the raised MCP-1 concentrations could be responsible for myocyte damage through monocyte activation and attraction.